Everest Organics Ltd. Share Price & Stock Analysis

Everest Organics Ltd. (BSE: 524790) is a Hyderabad, Telangana-based company in the Pharmaceuticals industry. With a market capitalisation of ₹241 Cr, it ranks #2,499 by market cap among the 6,197 Indian listed companies on FinBizNet, and #34 of 63 in Pharmaceuticals. At ₹255.40 (as of 16 Nov 2026), the share price is 52.4% below its 52-week high of ₹536.40 and 29.6% above its 52-week low of ₹197.00. The share price is down 36.6% over one year and down 17.0% over three months.

Key Metrics

Current Price₹255.40
Market Cap₹241 Cr
BSE Code524790
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio44.8
Return on Equity7.63%
Return on Assets3.76%
52-Week Range₹197.00 – ₹536.40
1-Year Price Change-36.6%
3-Month Price Change-17.0%
Beta (1Y)0.75
Dividend Yield0.00%
HeadquartersHyderabad, Telangana
Websitewww.everestorganicsltd.com

Latest Quarterly Results — Q1 FY27

Revenue₹48 Cr
Net Profit₹1 Cr
Net Margin2.3%
EPS (Basic)₹1.15
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Everest Organics Ltd. Quarterly Revenue and Profit Trend

Everest Organics Ltd. reported revenue of ₹48 Cr in Q1 FY27, down 10.0% from ₹54 Cr in Q1 FY26 and down 0.7% from ₹49 Cr in Q4 FY26. It posted a net profit of ₹1 Cr for the quarter, against a net profit of ₹1 Cr in Q1 FY26 (down 21.3%). Across the 8 quarters from Q2 FY25 to Q1 FY27, quarterly revenue ranged from ₹41 Cr (Q4 FY25) to ₹54 Cr (Q1 FY26). The company was profitable in each of these 8 quarters.

QuarterRevenueNet ProfitNet Margin
Q1 FY27₹48 Cr₹1 Cr2.3%
Q4 FY26₹49 Cr₹3 Cr5.4%
Q3 FY26₹43 Cr₹0 Cr0.8%
Q2 FY26₹51 Cr₹1 Cr2.3%
Q1 FY26₹54 Cr₹1 Cr2.6%
Q4 FY25₹41 Cr₹3 Cr7.1%
Q3 FY25₹42 Cr₹1 Cr2.7%
Q2 FY25₹44 Cr₹1 Cr1.7%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 50.22% of Everest Organics Ltd.'s shares as of Mar 2026, against 50.15% in Mar 2025 (+0.07 percentage points). Delivery averaged 83.9% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Everest Organics Ltd.

Everest Organics Limited engages in the manufacture and sale of active pharmaceutical ingredients and its intermediaries in India. It is also involved in the manufacturing of bulk drugs-related business. The company exports its products. Everest Organics Limited was incorporated in 1993 and is based in Hyderabad, India.

Products and Services

1. Active Pharmaceuticals Ingredients (API) and Their Intermediates-This segment manufactures and sells pharmaceutical products. It offers active pharmaceutical ingredients and intermediaries.

Business Segments

1. Active Pharmaceutical Ingredients (API) and Their Intermediaries-100%

Everest Organics Ltd. vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Everest Organics Ltd.₹241 Cr44.87.63%₹48 Cr-36.6%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Everest Organics Ltd.?

Everest Organics Ltd. is trading at ₹255.40, with a market capitalisation of ₹241 Cr.

Which sector does Everest Organics Ltd. belong to?

Everest Organics Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Everest Organics Ltd.?

Everest Organics Ltd. has a P/E of 44.8 and a return on equity of 7.63%.

What is the stock symbol of Everest Organics Ltd.?

Everest Organics Ltd. is listed on the BSE under the scrip code 524790.

How has Everest Organics Ltd.'s share price moved over the past year?

Everest Organics Ltd.'s share price is down 36.6% over one year and down 17.0% over three months. Its 52-week range is ₹197.00 to ₹536.40.

What were Everest Organics Ltd.'s latest quarterly results?

In Q1 FY27, Everest Organics Ltd. reported revenue of ₹48 Cr and net profit of ₹1 Cr, with basic EPS of ₹1.15 (standalone, parsed from the company's exchange filing).

How have Everest Organics Ltd.'s revenue and profit changed over the past year?

Everest Organics Ltd. reported revenue of ₹48 Cr in Q1 FY27, down 10.0% from ₹54 Cr in Q1 FY26 and down 0.7% from ₹49 Cr in Q4 FY26.

What is the promoter holding in Everest Organics Ltd.?

Promoters held 50.22% of Everest Organics Ltd.'s shares as of Mar 2026, against 50.15% in Mar 2025 (+0.07 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.